Synairgen (LON:SNG) Stock Price Passes Above 50 Day Moving Average of $5.45

Shares of Synairgen plc (LON:SNGGet Free Report) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 5.45 ($0.07) and traded as high as GBX 7.35 ($0.09). Synairgen shares last traded at GBX 7.02 ($0.09), with a volume of 30,405 shares changing hands.

Synairgen Price Performance

The company has a debt-to-equity ratio of 0.09, a current ratio of 6.77 and a quick ratio of 6.35. The stock has a market capitalization of £13.37 million, a P/E ratio of -140.40 and a beta of -2.23. The stock’s fifty day moving average is GBX 5.45 and its 200-day moving average is GBX 6.19.

Synairgen Company Profile

(Get Free Report)

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.

Further Reading

Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.